Early antiviral therapy of abidol combined with lopinavir/ritonavir and recombinant interferon α-2b for patients with COVID-19 in Zhejiang: A multicenter prospective study

Ran Wei; Naihang Zheng; Xieyuan Jiang; Chen Ma; Xiaowei Xu; Shouguo Liu; Yemeng Chen; Kaijin Xu; Hainv Gao; Jiansheng Zhu

doi:10.3760/cma.j.issn.1674-2397.2020.01.003

Early antiviral therapy of abidol combined with lopinavir/ritonavir and recombinant interferon α-2b for patients with COVID-19 in Zhejiang: A multicenter prospective study

Identifier:nobleid.org/w1/20260515/8CDF2F83

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/8CDF2F83.svg?ark=w1%2F20260515%2F8CDF2F83)](https://nobleid.org/work/w1/20260515/8CDF2F83)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Early antiviral therapy of abidol combined with lopinavir/ritonavir and recombinant interferon α-2b for patients with COVID-19 in Zhejiang: A multicenter prospective study

Identifier:nobleid.org/w1/20260515/8CDF2F83

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/8CDF2F83.svg?ark=w1%2F20260515%2F8CDF2F83)](https://nobleid.org/work/w1/20260515/8CDF2F83)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work